(22% among non-smokers) and 11% at work, including 8% of non-smoking women and 13% of non-smoking men [3] . About 25% of Poles are exposed to second-hand smoke at bus or tram stops. It is estimated that almost 3 million children in Poland are passive smokers. It is also estimated that about 20% of pregnant women are exposed to second-hand smoke at home. Therefore, it is necessary to increase the protection of non-smokers from the harmful effects of tobacco smoke.
SMOKING AND CARDIOVASCULAR DISEASES Smoking tobacco:
-carries a particularly high risk for patients with other risk factors, such as: hypertension, dyslipidaemia, diabetes, obesity, sedentary lifestyle, or positive family history of premature CV disease; -adversely affects blood vessels, damaging vascular endothelium and impacting vascular homeostasis; -increases inflammation, activates platelets and induces platelet aggregation, increases the expression of tissue factor, and impairs fibrinolysis; however. Cardiovascular risk decreases by half during the first year after smoking cessation. Subsequently it decreases gradually and after 15-20 years gets close to the level of never smokers.
EXPOSURE ASSESSMENT, THE DEGREE OF DEPENDENCE, AND MOTIVATION TO QUIT SMOKING
The assessment of exposure to tobacco smoke is made on the basis of an interview (small cost, subjective nature), which can be carried out using a questionnaire, and measurement of biomarkers (higher cost, objective measurement). Among others carbon monoxide in exhaled air, carboxyhaemoglobin in the blood, cotinine, nicotine, or thiocyanate in selected body fluids can be measured.
In assessing the degree of tobacco dependence the Fageström test is useful. It helps to differentiate smokers in whom physical dependence is less important, requiring mainly behavioural support, from smokers with primarily severe biologically dependence. The latter patients need intensive pharmacotherapy for effective smoking cessation. Depending on the number of points scored the addiction may be classified as: low (0-2 points), low to moderate (3-4 points), moderate (5-6 points), or high (≥ 7 points).
Motivation is the most important factor determining the success of any smoking cessation attempt. Those without strong motivation to quit smoking frequently return to it. Assessment of the degree of determination of the patient to make the effort required to process difficult behavioural changes (especially in the case of a behavioural addiction), and tuning of the organism to function in the absence of nicotine (in the case of a significant component of physical addiction) is essential. Although CV risk does not influence the treatment of smoking dependence it can be used to further motivate the patient [4] [5] [6] . In the Polish population the Pol-SCORE 2015 system should be used (also for the heart age estimation) [7, 8] .
GOAL OF THERAPY
The aim of the treatment is complete smoking cessation. The success of therapy is defined as non-smoking for at least six months. However, many people who have managed to achieve this goal eventually return to smoking.
GENERAL STRATEGY OF TOBACCO DEPENDENCE TREATMENT
Each patient must be made aware that addiction to tobacco is a disease that can and should be treated. In routine practice the "Five As" counselling strategy should be followed [1, [4] [5] [6] : -Ask -systematically identify all tobacco users at every opportunity; -Advise -strongly urge all tobacco users to quit; -Assess -determine the degree of addiction and readiness to quit; -Assist -agree on a smoking cessation strategy, including setting a quit date. Aid the patient in quitting (provide counselling-style support and medication); -Arrange -ensure follow-up contact.
NON-PHARMACOLOGICAL TREATMENT
Medical intervention may be limited to brief counselling when directed, mainly to those smoking patients who do not yet take into account smoking cessation. Although the six-month effectiveness of short medical advice is estimated to be 2-3%, if every doctor in Poland gave this advice to all his/her smoking patients about 100,000 persons would stop smoking in Poland yearly [4, 6] .
Every smoking patient should be advised to stop smoking during each visit in the doctor's office. Medical risks related to smoking, as well as medical and personal benefits of breaking the addiction, should always be underlined. Patients should be informed about much more effective smoking cessation attempts if they are supported by pharmacological or behavioural therapy. The physician should remember: the more intense intervention, the greater the chance of smoking cessation. Interventions involving periodic telephone contact, providing practical guidelines for behaviour in the period of cessation, and providing social support are especially effective.
PHARMACOLOGICAL TREATMENT
Pharmacotherapy tobacco dependence should be seen in the same way as the pharmacological treatment of other risk factors. Available data indicate that drug treatment of tobacco dependence in Poland is used too rarely. Treatment of tobacco dependence is one of the most cost-effective methods in modern medicine, so it seems reasonable to introduce a partial reimbursement for drugs used for the treatment of tobacco dependence [4] [5] [6] .
Pharmacotherapy should be offered to anyone planning to stop smoking, especially those with severe dependence or complications of smoking (e.g. coronary artery disease, chronic obstructive pulmonary disease) [1, [4] [5] [6] .
Pharmacological treatment of tobacco dependence syndrome may consist of a nicotine replacement therapy (NRT), bupropion, cytisine, or varenicline [1, [4] [5] [6] 9] .
Nicotine replacement therapy may take the form of patches, gums, lozenges, sublingual tablets, inhalers, etc. All available forms of NRT are effective and relatively safe. Combined NRT (patches + NRT in a form that provides a rapid increase in the level of blood nicotine, e.g. gums, inhalers) is more effective than NRT in monotherapy, especially in patients with severe addiction or in those who failed to stop smoking. NRT is available in Poland without a prescription. Other drugs registered in Poland include: bupropion, cytisine, and varenicline. Of these, cytisine is available without a prescription. Cytisine may be a useful alternative to more expensive drugs. The most effective method is a combination of pharmacological treatment with behavioural intervention.
ELECTRONIC CIGARETTES
Currently, about 3% of adults use electronic cigarettes in Poland [3] . Although they are less harmful than traditional tobacco products the public should not be encouraged to use them because there is no evidence that they are more effective than traditional methods of tobacco dependence treatment and due to the risk of initiation of smoking (especially in adolescents and young adults). People who smoke traditional cigarettes and intend to use electronic cigarettes as a means of tobacco dependence treatment should be informed of the relatively small evidence of their effectiveness and lack of certainty as to their full safety. At the same time, patients should be encouraged to use methods that are proven to be effective [1, 10, 11] .
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